ArticleExploration of targeted anti-tumor therapy2020

Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer.

Milene Volpato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.